Abstract: The present invention provides topical dermal compositions including the compositions of the invention are useful for treating a variety of conditions associated with excess sebum production, such as, for example, acne.

Abstract: The present invention provides topical dermal compositions useful for treating a variety of conditions associated with excess sebum production, such as for example acne.

Abstract: A transformer includes a bobbin, a winding coil assembly, a magnetic core assembly, and a bracket. The bobbin includes a supporting part and a winding part. The winding coil assembly includes a primary winding coil and a secondary winding coil. The secondary winding coil has an outlet part. The primary winding coil and the secondary winding coil are wound around the winding part of the bobbin. The magnetic core assembly includes a first magnetic core and a second magnetic core. The bobbin is arranged between the first magnetic core and the second magnetic core. The bracket is connected with the supporting part of the bobbin for assisting in positioning the outlet part of the secondary winding coil.

Abstract: A transformer includes a bobbin, a winding coil assembly, a magnetic core assembly, and a bracket. The bobbin includes a supporting part and a winding part. The winding coil assembly includes a primary winding coil and a secondary winding coil. The secondary winding coil has an outlet part. The primary winding coil and the secondary winding coil are wound around the winding part of the bobbin. The magnetic core assembly includes a first magnetic core and a second magnetic core. The bobbin is arranged between the first magnetic core and the second magnetic core. The bracket is connected with the supporting part of the bobbin for assisting in positioning the outlet part of the secondary winding coil.

Abstract: The present disclosure provides a convertor for X-ray radiography and its manufacturing method and an X-ray detector, wherein the surface of the scintillator facing the X-ray is covered with photonic crystals of a two-dimensional or three-dimensional spatial structure capable of reflecting the visible light facing the photonic crystals generated by the scintillator to increase the intensity of the output light of the scintillator by more than 100%, thus enhancing the image brightness and improving the image resolution, in addition to reducing to a certain extent the interference between pixels due to the ability of the photonic crystals to control the direction of the light being reflected, for example, by controlling the reflecting direction so as to be vertical to the surface of the scintillator, and the manufacturing method and material for the photonic crystals are low in cost without toxicity, enabling it to be used more widely.

Abstract: The present invention relates to electric equipment field, and relates particularly to a novel water-cooling radiator of thyristor. This radiator flow channel design adopted helical flow channel combined with cellular fin structure. There are some advantages of this design: the flow resistance and thermal resistance is smaller, radiator surface temperature is homogeneous, heat change of inner water is enough, there are no flow dead zone and partial heat accumulation, the thermal resistance and the flow resistance are all adjusted according to design requirements by changing the circle number of helical flow channel and the layer number of cellular fin.

Abstract: The present disclosure provides a convertor for X-ray radiography and its manufacturing method and an X-ray detector, wherein the surface of the scintillator facing the X-ray is covered with photonic crystals of a two-dimensional or three-dimensional spatial structure capable of reflecting the visible light facing the photonic crystals generated by the scintillator to increase the intensity of the output light of the scintillator by more than 100%, thus enhancing the image brightness and improving the image resolution, in addition to reducing to a certain extent the interference between pixels due to the ability of the photonic crystals to control the direction of the light being reflected, for example, by controlling the reflecting direction so as to be vertical to the surface of the scintillator, and the manufacturing method and material for the photonic crystals are low in cost without toxicity, enabling it to be used more widely.

Abstract: A manufacturing method for a semiconductor-device isolation structure comprises providing a substrate with at least one shallow trench isolation structure, performing a salicide process that forms a recess on the surface of the shallow trench isolation structure, forming a cap film covering the substrate and filling the recess, performing an etching process to remove the cap film outside the recess, and forming a contact etch stop layer covering the substrate and filling the recess. Due to the filling recess with the cap film first, the contact etch stop layer covering the substrate and filling the recess does not have seams or voids.

Abstract: A computer aided method and apparatus are disclosed. In at least one embodiment, the method includes acquiring image data of a scanned location of a subject by performing a nuclear magnetic resonance scan thereon, and displaying via a user interface an image formed by the image data; determining particular feature information by using an image segmentation algorithm to the image, determining the position of an acupotome insertion point according to the particular feature information, and displaying the position of the acupotome insertion point on the image.

Abstract: A manufacturing method for a semiconductor-device isolation structure comprises providing a substrate with at least one shallow trench isolation structure, performing a salicide process that forms a recess on the surface of the shallow trench isolation structure, forming a cap film covering the substrate and filling the recess, performing an etching process to remove the cap film outside the recess, and forming a contact etch stop layer covering the substrate and filling the recess. Due to the filling recess with the cap film first, the contact etch stop layer covering the substrate and filling the recess does not have seams or voids.

Abstract: Orally deliverable pharmaceutical compositions are provided comprising a drug of tow water solubility suspended in an aqueous liquid vehicle comprising a wetting agent, a thixotropic thickening agent, and an inorganic suspending agent. The compositions are thixotropic, substantially deflocculated, and substantially physically stable.

Abstract: The invention provides therapies for treating human papillomavirus.

Abstract: A pharmaceutical composition for application to an area of skin of a subject for local and/or systemic treatment of a COX-2 mediated disorder comprises a backing sheet that is flexibly conformable to the area of skin, the backing sheet having opposing surfaces that are respectively distal and proximal to the skin when applied; and a coating on the proximal surface of the backing sheet that comprises (a) an adhesive and (b) a water-soluble active agent selected from selective COX-2 inhibitory drugs, prodrugs and salts thereof, the active agent being in a therapeutically effective total amount and dispersed in a matrix that comprises zero to less than an active agent solubilizing effective amount in total of one or more solvents other than the adhesive.

Abstract: A pharmaceutical composition for application to an area of skin of a subject for local and/or systemic treatment of a COX-2 mediated disorder comprises a backing sheet that is flexibly conformable to the area of skin, the backing sheet having opposing surfaces that are respectively distal and proximal to the skin when applied; and a coating on the proximal surface of the backing sheet that comprises (a) an adhesive and (b) an active agent comprising valdecoxib or a prodrug thereof or a salt thereof, the active agent being in a therapeutically effective total amount and dispersed in a matrix that comprises zero to less than an active agent solubilizing effective amount in total of one or more solvents other than the adhesive.

Abstract: A dermally deliverable pharmaceutical composition comprises at least one selective cyclooxygenase-2 (COX-2) inhibitory drug or prodrug thereof solubilized in a pharmaceutically acceptable carrier that comprises a low molecular weight monohydric alcohol, and exhibits a skin permeation rate of the therapeutic agent at least equal to that exhibited by a reference solution of the therapeutic agent in 70% aqueous ethanol. A method of effecting targeted delivery of a selective COX-2 inhibitory drug to a site of pain and/or inflammation in a subject comprises topically administering such a composition to skin of the subject, preferably at a locus overlying or adjacent to the site of pain and/or inflammation. A method of effecting systemic treatment of a subject having a COX-2 mediated disorder comprises transdermally administering such a composition, preferably by contacting the composition with an area of skin of the subject not greater than about 400 cm2.

Abstract: A pharmaceutical composition suitable for oral administration is provided, the composition comprising an aqueous medium having suspended therein a solid substance of low water solubility in particulate form, and further comprising a suspending agent and at least one pharmaceutically acceptable water-soluble or swellable nonsurfactant polymer, the total amount of all such polymers present being ineffective to (a) increase viscosity of the composition to a degree that significantly impairs pourability, or (b) significantly increase rate of sedimentation or phase separation, of the composition. The composition has improved mouth feel.

Abstract: Orally deliverable pharmaceutical compositions are provided comprising a drug of low water solubility suspended in an aqueous liquid vehicle comprising a wetting agent, a thixotropic thickening agent, and an inorganic suspending agent. The compositions are thixotropic, substantially deflocculated, and substantially physically stable.

Abstract: A fluorosurfactant, preferably an anionic fluorosurfactant, can be added to the anode mixture of a zinc/air cell. A desirable surfactant is an anionic fluoroaliphaticcarboxylate. The addition of the surfactant reduces gassing and improves cell performance. The anode casing can also be treated with the surfactant solution prior to inserting the anode mixture therein. The anode casing of a zinc/air depolarized cell can also be heat treated after the casing has been formed but before anode material comprising zinc is inserted therein. The anode casing has a layer of copper on its inside surface. The process comprises heat treating the anode casing by passing a gas at a temperature between about 200° C. and 700° C., preferably between about 300° C. and 600° C. in contact therewith to form a heat treated anode casing and then cooling said heat treated anode casing to ambient temperature.

Abstract: A process for heat treating the metal sheeting forming the anode casing of a zinc/air depolarized cell before anode material comprising zinc is inserted into the anode casing. The anode casing has a layer of copper on its inside surface. The process comprises heat treating the metal sheeting forming the anode casing by passing a gas at a temperature between about 200° C. and 700° C., preferably between about 300° C. and 600° C. in contact therewith to form a heat treated sheeting and then cooling said heat treated sheeting to ambient temperature. The anode casing is stored away from atmospheric air until anode active material is inserted therein during cell assembly. The heat treating process significantly reduces gassing during cell discharge and storage. The cell's capacity and performance is improved when the cell's anode comprises particulate zinc (or zinc alloy) plated with indium, preferably between about 200 and 600 ppm indium.

Abstract: An alkaline battery has a cathode including a nickel oxyhydroxide.